Ornidazole 250 mg + Diloxanide Furoate 375 mg + Simethicone 25 mg Tablet – Manufacturer, Supplier & PCD Franchise



Ornidazole 250 mg + Diloxanide Furoate 375 mg + Simethicone 25 mg Tablet — available for PCD franchise from Trumac Healthcare

Ornidazole 250 mg + Diloxanide Furoate 375 mg + Simethicone 25 mg Tablet

Ornidazole 250 mg + Diloxanide Furoate 375 mg + Simethicone 25 mg — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing

Composition: Ornidazole 250 mg + Diloxanide Furoate 375 mg + Simethicone 25 mg
Form: Tablet
Class: Fixed-Dose Combination — Nitroimidazole antimicrobial + Luminal amoebicide + Antiflatulent
✓ WHO-GMP
✓ Pan-India Monopoly PCD
✓ Available Now

Pricing, brochure & monopoly territory within 24 hrs.

Ornidazole 250 mg + Diloxanide Furoate 375 mg + Simethicone 25 mg Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.

Therapeutic Indications
  • Amoebiasis and giardiasis
  • Infectious diarrhoea of mixed bacterial-protozoal origin (in combination)
  • Intestinal amoebiasis, including asymptomatic cyst passers
  • Mixed amoebic and giardial infections with nitroimidazoles
  • Bloating, flatulence and abdominal distension
  • Gas discomfort with acidity, combined with antacids
Mechanism of Action

Ornidazole — Ornidazole is reduced inside anaerobic bacteria and protozoa to reactive intermediates that damage their DNA, killing the organisms. It is active against Entamoeba, Giardia, Trichomonas and anaerobic bacteria.

Diloxanide Furoate — Acts within the bowel lumen to kill Entamoeba histolytica trophozoites, preventing cyst formation; mechanism is thought to involve inhibition of protozoal protein synthesis.

Simethicone — Simethicone lowers the surface tension of gas bubbles in the stomach and intestines, causing them to merge and be expelled more easily by belching or flatus. It is not absorbed into the body.

Combining these ingredients in one tablet provides complementary action on the target condition and simplifies therapy compared with taking the components separately.

Dosage & Administration
  • Dosage of Ornidazole 250 mg + Diloxanide Furoate 375 mg + Simethicone 25 mg Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
  • Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
  • Do not exceed the prescribed dose, and complete the full course as advised.
  • Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
  • To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
  • Nausea and metallic taste
  • Abdominal discomfort
  • Headache and dizziness
  • Flatulence
  • Nausea and vomiting
  • Generally well tolerated
  • Mild constipation or loose stools
Contraindications
  • Known hypersensitivity to any component of the formulation
  • Hypersensitivity to nitroimidazoles
  • Neurological disorders such as epilepsy
  • Pregnancy, especially first trimester
  • Persistent abdominal pain needs medical evaluation
Storage

Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.

Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the general range pharma franchise product list (PDF). See our full tablet range for PCD franchise. Comparing companies? See the general range PCD companies compared. No franchise fee; minimum first order ₹25,000 – cost and documents.


For chemists, distributors and doctors: need Ornidazole 250 mg + Diloxanide Furoate 375 mg + Simethicone 25 mg Tablet for a PCD franchise or wholesale? Trumac Healthcare checks availability with its WHO-GMP certified partner units and quotes on enquiry – no franchise fee; first order from ₹25,000.

WhatsApp your requirement

See the full antibiotic range – manufacturer, supplier and PCD franchise: cefixime, cefpodoxime, cefuroxime, amoxicillin-clavulanate, azithromycin, levofloxacin, doxycycline, faropenem and linezolid.

PCD Pharma Franchise & Third Party Manufacturing — Ornidazole + Diloxanide Furoate + Simethicone Tablet

  • ✓ Made at WHO-GMP certified partner units — every batch QC released
  • ✓ Monopoly PCD franchise rights at district or state level
  • ✓ Third party / contract manufacturing under your own brand
  • ✓ Wholesale and distributor supply against drug licence + GST
  • ✓ Attractive net rates with healthy PTR / PTS margins
  • ✓ Dispatch within 48 hours of payment realisation

Composition: Ornidazole 250 mg + Diloxanide Furoate 375 mg + Simethicone 25 mg. It is a fixed-dose combination of nitroimidazole antimicrobial, luminal amoebicide and antiflatulent. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.

Ornidazole + Diloxanide Furoate + Simethicone Tablet brings together Ornidazole (nitroimidazole antimicrobial), Diloxanide Furoate (luminal amoebicide) and Simethicone (antiflatulent) in a single fixed-dose formulation.

PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Ornidazole + Diloxanide Furoate + Simethicone Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.

Frequently Asked Questions

Who manufactures Ornidazole + Diloxanide Furoate + Simethicone Tablet in India?

Trumac Healthcare is a supplier of Ornidazole + Diloxanide Furoate + Simethicone Tablet in India; products are made at WHO-GMP certified partner units. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.

What is Ornidazole + Diloxanide Furoate + Simethicone Tablet used for?

Ornidazole + Diloxanide Furoate + Simethicone Tablet is used for amoebiasis and giardiasis; infectious diarrhoea of mixed bacterial-protozoal origin (in combination); intestinal amoebiasis, including asymptomatic cyst passers; mixed amoebic and giardial infections with nitroimidazoles. It should be used as advised by a registered medical practitioner.

Is Ornidazole + Diloxanide Furoate + Simethicone Tablet available for PCD pharma franchise on monopoly basis?

Yes. Ornidazole 250 mg + Diloxanide Furoate 375 mg + Simethicone 25 mg Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.

Do you offer Ornidazole + Diloxanide Furoate + Simethicone for third party or contract manufacturing?

Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Ornidazole + Diloxanide Furoate + Simethicone Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.

Can Ornidazole + Diloxanide Furoate + Simethicone Tablet be supplied on wholesale or distributor basis?

Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.

What is the therapeutic class of Ornidazole + Diloxanide Furoate + Simethicone?

Ornidazole + Diloxanide Furoate + Simethicone is a fixed-dose combination of nitroimidazole antimicrobial, luminal amoebicide and antiflatulent (therapeutic class: Fixed-Dose Combination — Nitroimidazole antimicrobial + Luminal amoebicide + Antiflatulent).

What documentation is provided with each supply?

Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.

How quickly can an order be dispatched?

Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.

Is a prescription required for Ornidazole + Diloxanide Furoate + Simethicone Tablet?

Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.

Ready to start your PCD franchise for Ornidazole 250 mg + Diloxanide Furoate 375 mg + Simethicone 25 mg Tablet?

Get Pricing & Franchise Terms →